Cargando…
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
BACKGROUND: Vancomycin has been used in clinical practice for over 50 years; however, validated, pharmacokinetic (PK) data relating clinical outcomes to different dosing regimens in neonates are lacking. Coagulase negative staphylococci (CoNS) are the most commonly isolated organisms in neonatal, la...
Autores principales: | Hill, Louise F., Turner, Mark A., Lutsar, Irja, Heath, Paul T., Hardy, Pollyanna, Linsell, Louise, Jacqz-Aigrain, Evelyne, Roilides, Emmanuel, Sharland, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158076/ https://www.ncbi.nlm.nih.gov/pubmed/32293527 http://dx.doi.org/10.1186/s13063-020-4184-8 |
Ejemplares similares
-
Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis
por: D’Agate, S., et al.
Publicado: (2021) -
Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
por: Mulubwa, Mwila, et al.
Publicado: (2020) -
Prospective validation of neonatal vancomycin dosing regimens is urgently needed
por: Vandendriessche, Anaïs, et al.
Publicado: (2014) -
Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
por: Padari, Helgi, et al.
Publicado: (2016) -
Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
por: Kim, Dae Il, et al.
Publicado: (2010)